XML 83 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES      
NET INCOME $ 96,734 $ 70,061 $ 12,974
ADJUSTMENTS TO RECONCILE NET INCOME TO NET CASH PROVIDED BY OPERATING ACTIVITIES:      
Depreciation and amortization 40,685 40,286 40,599
Earnings from equity-accounted investments (452) (298) (351)
Fair value adjustment 248 (55) 631
Interest payable 1,283 2,100 4,313
Facility fee amortized 208 738 302
(Profit) Loss on disposal of property, plant and equipment (296) (434) 110
Loss (Profit) on deconsolidation of subsidiaries and business (Note 19)   55  
Stock-based compensation charge, net of forfeitures (Note 18) 3,195 3,718 3,907
Fair value of BEE equity instruments granted (Note 17)   11,268  
Decrease (Increase) in accounts and finance loans receivable, and pre-funded grants receivable 1,399 (101,447) (5,726)
(Increase) Decrease in inventory (3,846) 780 (2,890)
(Decrease) Increase in accounts payables and other payables (850) 12,671 8,113
Increase (Decrease) in taxes payable 606 5,523 (2,748)
Decrease in deferred taxes (3,656) (7,821) (3,317)
NET CASH PROVIDED BY OPERATING ACTIVITIES 135,258 37,145 55,917
CASH FLOWS FROM INVESTING ACTIVITIES      
Capital expenditures (36,436) (23,906) (22,747)
Proceeds from disposal of property, plant and equipment 857 2,990 510
Net cash outflow from sale of MediKredit (Note 19)   (669)  
Proceeds from sale of business (Note 19) 1,895 186  
(Acquisition of equity of)/Capital reduction/ repayment of loan by equity-accounted investment (13,200) 539 3
Acquisitions, net of cash acquired (Note 3)     (2,143)
Other investing activities, net (29) 570 545
Net change in settlement assets (12,570) (1,350) (423,984)
NET CASH USED IN INVESTING ACTIVITIES (59,483) (21,640) (447,816)
CASH FLOW FROM FINANCING ACTIVITIES      
Repayment of long-term borrowings (Note 13) (14,128) (87,008) (14,508)
Long-term borrowings obtained (Note 13) 3,765 73,677  
Acquisition of treasury stock (Note 14) (9,151)    
Sale of equity to non-controlling interest (Note 14) 1,407    
Dividends paid to non-controlling interest (1,024)    
Proceeds from issue of common stock (Note 18) 2,045 198 240
Payment of facility fee (Note 13)   (872)  
Proceeds from bank overdraft   24,580  
Repayment of bank overdraft   (23,335)  
Acquisition of interests in KSNET (Note 14)   (1,968)  
Net change in settlement obligations 12,570 1,350 423,984
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (4,516) (13,378) 409,716
Effect of exchange rate changes on cash (12,348) 2,880 (3,275)
NET INCREASE IN CASH AND CASH EQUIVALENTS 58,911 5,007 14,542
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR 58,672 53,665 39,123
CASH AND CASH EQUIVALENTS AT END OF YEAR $ 117,583 $ 58,672 $ 53,665